Hasil Pencarian  ::  Simpan CSV :: Kembali

"Latar belakang: Operasi jantung terbuka dengan menggunakan mesin bypass kardiopulmoner (CPB) berpotensi menimbulkan respons inflamasi yang signifikan. Salah satu penyebab respons inflamasi ini adalah kontak darah dengan sirkuit ekstrakorporeal dan shear stress non-fisiologis selama operasi pompa CPB. Penelitian ini bertujuan untuk menentukan teknik mana yang menghasilkan respons sindrom inflamasi sistemik (SIRS) yang lebih ringan.Metode: Penelitian kohort retrospektif. Pengambilan data dilakukan di Rumah Sakit Jantung dan Pembuluh Darah Harapan Kita (RSJPDHK) sejak Juli 2018 hingga Februari 2023. Subjek yang direkrut secara konsekutif adalah pasien dengan diagnosis penyakit jantung koroner yang menjalani operasi bedah pintas arteri koroner, baik dengan menggunakan teknik CCABG atau dengan teknik OPCAB. Setelahnya subjek dilakukan pemeriksaan IL-6 pada 6 jam pasca operasi, CRP dan PCT pada 6, 24, dan 48 jam pascaoperasi. Setelahnya, pasien dinilai keluaran SIRS dan mortalitasnya.Hasil: Total subjek penelitian ada 70 subjek, dengan perbandingan laki-laki yang menjalani OPCAB (82,9%) dan CCABG (91,4%), sisanya berjenis kelamin perempuan. Terdapat perbedaan bermakna antara SIRS dengan jenis operasi (p = 0,048). Kadar IL-6 pada 6 jam pascaoperasi menunjukkan hasil berbeda bermakna dengan jenis operasi (0,014). Pada 24 jam pascaoperasi, penanda inflamasi menunjukkan hasil berbeda bermakna pada CRP (p = 0,013) dan PCT (0,001). Sedangkan pada 48 jam pascaoperasi juga menunjukkan hasil berbeda bermakna pada CRP (p = 0,002) dan PCT (p = 0,022). Peningkatan angka kejadian aritmia pada CCABG menunjukkan perbedaan bermakna juga dengan nilai p <0,001 (IK95% 6,14(1,63-23,16)).

---

Background: Open heart surgery using a cardiopulmonary bypass (CPB) machine has the potential to induce a significant inflammatory response. One of the causes of this inflammatory response is blood contact with the extracorporeal circuit and non-physiological shear stress during CPB pump operation. This study aims to determine which technique yields a milder systemic inflammatory response syndrome (SIRS) outcome.

Method: This is a retrospective cohort study. Data collection was conducted at Harapan Kita Heart and Blood Vessel Hospital (RSJPDHK) from July 2018 to February 2023. Consecutively recruited subjects were patients diagnosed with coronary heart disease who underwent coronary artery bypass grafting (CABG) surgery, either using the conventional technique (CCABG) or off-pump technique (OPCAB). Subsequently, IL-6 levels were examined at 6 hours post-surgery, while CRP and PCT levels were measured at 6, 24, and 48 hours post-surgery. Following these assessments, patients were evaluated for the occurrence of systemic inflammatory response syndrome (SIRS) and mortality.

Result: There were a total of 70 subjects, with a comparison of males who underwent OPCAB (82.9%) and CCABG (91.4%), the rest were female. There was a significant difference between SIRS and the type of surgery (p = 0.048). IL-6 levels at 6 hours postoperatively showed significantly different results with the type of surgery (0.014). At 24 hours postoperatively, inflammatory markers showed significantly different results for CRP (p = 0.013) and PCT (0.001). Whereas at 48 hours postoperatively it also showed significantly different results on CRP (p = 0.002) and PCT (p = 0.022). The increase in the incidence of arrhythmias in CCABG also showed a significant difference with a value of p <0.001 (95%CI 6.14 (1.63-23.16)).

"

"Latar belakang: Berdasarkan pilot study di divisi Bedah Jantung Dewasa Rumah Sakit Pusat Jantung dan Pembuluh Darah Harapan Kita, SIRS lebih sering terjadi pada OPCAB dibandingkan dengan on-pump CABG, 67% vs 33% (30 sampel, 2017). Berangkat dari hal tersebut, peneliti melakukan uji klinis memberikan deksametason pada pasien yang menjalani operasi OPCAB. Metode: Pengumpulan sampel dilakukan secara konsekutif di divisi Bedah Jantung Dewasa Rumah Sakit Pusat Jantung dan Pembuluh Darah Harapan Kita antara Agustus 2018 - Januari 2019. Sampel yang memenuhi kriteria inklusi dan eksklusi dirandomisasi menjadi grup deksametason (n=30) dan grup plasebo (n=30). Intervensi deksametason intravena dosis 1 mg/KgBB (maksimal 100 mg) atau plasebo menggunakan normal salin (NaCl 0,9%). Analisis statistik digunakan independent t-test, Mann-Whitney test, fisher exact test dan AUC. Hasil: Insiden MACE pada grup deksametason dibandingkan grup plasebo (RR 0,385, CI 95%: 0,157-0,945, p = 0,024). Keluaran klinis lebih baik ditemukan pada grup deksametason dibandingkan grup plasebo untuk durasi ventilasi mekanik (6 (5-16) jam vs 8 (5-72) jam, p = 0,029), lama rawat ICU (17,5 (12-32) jam vs 19 (13-168) jam, p = 0,028), lama rawat rumah sakit (5 (5-8) hari vs 6,5 (5-30) hari, p = 0,04) dan VIS (0 (0-15) vs 5 (0-100), p = 0,045). Hasil penanda inflamasi, terdapat perbedaan rata-rata yang bermakna antara grup deksametason dibandingkan grup plasebo pada IL-6 (217,4 pg/mL, CI 95%: 107,9-326,8, p = 0,0001), PCT (3,41 µg/L, CI 95%: 2,1-4,71, p = 0,0001) dan CRP (52,3 mg/L, CI 95%: 28.8-75,8, p = 0,0001). Pada analisis AUC terdapat hubungan signifikan antara penanda inflamasi dengan insiden MACE pada IL-6 (AUC 0,728, CI 95%: 0,585-0,871, p = 0,005) dan PCT (AUC 0,723, CI 95%: 0,578-0,868, p = 0,007). Kesimpulan: Pemberian deksametason praoperasi OPCAB, efektif memperbaiki keluaran klinis dan mengendalikan reaksi inflamasi pascaoperasi dibandingkan plasebo.

---

Background: Based on a pilot study in the Adult Heart Surgery division of Harapan Kita Heart and Vascular Center Hospital, SIRS is more common in OPCAB compared to on-pump CABG, 67% vs 33% (30 samples, 2017). Based from this result, this research conducted a clinical trial to provide dexamethasone in patients undergoing OPCAB surgery. Methods: Samples were collected consecutively in the Adult Heart Surgery division of Harapan Kita Heart and Vascular Center Hospital between August 2018 - January 2019. Samples that fulfill inclusion and exclusion criteria were randomized to dexamethasone group (n=30) and placebo group (n=30). Intervention using intravenous dexamethasone dose of 1 mg/KgBB (maximum 100 mg) or placebo using normal saline (0.9% NaCl). Statistical analysis were used independent t-test, Mann-Whitney test, fisher exact test and AUC. Results: MACE incidence in dexamethasone group compared to placebo group (RR 0.385, 95% CI: 0.157-0.945, p = 0.024). Clinical output of dexamethasone group was better than placebo group in duration of mechanical ventilation (6 (5-16) hours vs 8 (5-72 ) hours, p = 0.029), ICU length of stay (17.5 (12-32) hours vs 19 (13-168) hours, p = 0.028), hospital length of stay (5 (5-8) days vs 6.5 (5-30) days, p = 0.04) and VIS (0 (0-15) vs 5 (0-100), p = 0.045). As a result of the inflammatory markers, there was a significant average difference between dexamethasone group compared to the placebo group in IL-6 (217.4 pg/mL, 95% CI: 107.9-326.8, p = 0,0001), PCT ( 3.41 µg/L, 95% CI: 2.1-4.71, p = 0.0001) and CRP (52.3 mg/L, 95% CI: 28.8-75.8, p = 0.0001 ) In the AUC analysis there was a significant association between inflammatory markers with the incidence of MACE in IL-6 (AUC 0.728, 95% CI: 0.585-0.871, p = 0.005) and PCT (AUC 0.723, 95% CI: 0.578-0.868, p = 0.007). Conclusion: Preoperative dexamethasone OPCAB is effective to improving clinical output and controlling postoperative inflammatory reactions compared to placebo."